A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy
Robert A. WoodJohns Hopkins University School of Medicine, Baltimore, MdJennifer S. KimNorthShore University HealthSystem, Evanston, IllRobert LindbladEMMES Corporation, Rockville, MdKari C. NadeauStanford University School of Medicine, Stanford, CalifAlice K. HenningEMMES Corporation, Rockville, MdPeter DawsonEMMES Corporation, Rockville, MdMarshall PlautNational Institute of Allergy and Infectious Diseases, Bethesda, MdHugh A. SampsonIcahn School of Medicine at Mount Sinai, New York, NY. Electronic address: [email protected]
2015en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references